Co-Diagnostics, Inc. Reports that Suite of COVID-19 Diagnost

Co-Diagnostics, Inc. Reports that Suite of COVID-19 Diagnostics Not Affected by Heavily Mutated Omicron Variant

SALT LAKE CITY, Nov. 29, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) (the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,

Related Keywords

China , South Africa , Utah , United States , Dwight Egan , Diagnostics Inc , World Health Organization , Nasdaq , Prnewswire Co , Logix Smart , Looking Statements , Prnewswire , ,